000 01543 a2200409 4500
005 20250513213906.0
264 0 _c20000727
008 200007s 0 0 eng d
022 _a1102-416X
024 7 _a10.1080/11024159950188583
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarshall, J C
245 0 0 _aOrgan dysfunction as an outcome measure in clinical trials.
_h[electronic resource]
260 _bThe European journal of surgery. Supplement. : = Acta chirurgica. Supplement
_c1999
300 _a62-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCardiac Surgical Procedures
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aCritical Care
650 0 4 _aHealth Care Costs
650 0 4 _aHealth Status Indicators
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
_xtherapeutic use
650 0 4 _aLength of Stay
650 0 4 _aMediastinitis
_xtherapy
650 0 4 _aMultiple Organ Failure
_xclassification
650 0 4 _aOutcome Assessment, Health Care
650 0 4 _aReproducibility of Results
650 0 4 _aSeverity of Illness Index
650 0 4 _aSurgical Wound Infection
_xtherapy
650 0 4 _aSurvival Rate
650 0 4 _aSyndrome
650 0 4 _aSystemic Inflammatory Response Syndrome
_xclassification
650 0 4 _aTime Factors
773 0 _tThe European journal of surgery. Supplement. : = Acta chirurgica. Supplement
_gno. 584
_gp. 62-7
856 4 0 _uhttps://doi.org/10.1080/11024159950188583
_zAvailable from publisher's website
999 _c10840713
_d10840713